{
  "id": 12854931,
  "title": "Medication helps adults with ADHD weigh the negative consequences of their decisions",
  "url": "https://urgent.news/2026/10/08/medication-helps-adults-with-adhd-weigh-the-negative-consequences-of",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-08T11:00:29.000Z",
  "source": {
    "name": "PsyPost",
    "slug": "psypost",
    "url": "https://www.psypost.org/medication-helps-adults-with-adhd-weigh-the-negative-consequences-of-their-decis/"
  },
  "original_language": "en",
  "account": "Adults grappling with attention deficit hyperactivity disorder (ADHD) often wrestle with choices that weigh potential gains against downsides. A recent study published in *Psychological Medicine* suggests a common stimulant medication can enhance decision-making by sharpening individuals' focus on the negative repercussions of their actions. ADHD is a neurodevelopmental condition marked by inattention, hyperactivity, and impulsive behavior, leading to issues like reckless driving, substance abuse, and risky sexual behavior. Everyday life presents numerous decisions requiring balancing potential benefits against drawbacks, such as the allure of a new gadget against the cost of diminished funds for essentials. Neurobiological theories propose that atypical functioning of dopamine and norepinephrine neurotransmitters, responsible for attention, reward processing, and cognitive effort, underpins the disorder. Stimulant medications, such as methylphenidate (commonly known as Ritalin), augment the availability of these brain chemicals. While researchers acknowledge that stimulants generally improve decision-making, the precise psychological mechanisms behind this enhancement remain unclear. To unravel these mechanisms, a team led by psychologist Mads Lund Pedersen at the University of Oslo conducted an experiment involving 61 adults diagnosed with ADHD and 63 healthy controls. The study used a double-blind, placebo-controlled crossover design, where participants with ADHD completed two test sessions - one after taking methylphenidate and another after taking a placebo. Control participants also underwent two sessions without medication. Participants engaged in a computer-based task testing their ability to integrate costs and benefits. They initially learned that specific shapes corresponded to numerical rewards while particular colors signified numerical costs. In the main testing phase, the computer displayed a shape and color for a brief moment, and participants had to decide, based on the combined benefit and cost values, whether to accept or reject the offer. Using the drift diffusion model, researchers dissected the cognitive components involved in decision-making. This model separates the rapid choice-making process into distinct components, including the drift rate (speed and efficiency of accumulating evidence), decision threshold (information needed to commit to an action), and non-decision time (the physical time taken to perceive the image and respond). Among the ADHD participants, those not on medication performed less accurately than the healthy controls. The unmedicated ADHD group exhibited reduced drift rate, indicating slower evidence accumulation about both costs and benefits, and a narrower decision threshold, showing they acted on less information and rushed to conclusions. When it came to balancing positive and negative information, healthy controls typically emphasized costs more than benefits. Conversely, unmedicated ADHD participants showed the opposite pattern, demonstrating heightened sensitivity to benefits over costs. Methylphenidate altered their processing, increasing the drift rate, which enhanced the efficiency of accumulating cost-related information, while leaving their sensitivity to benefits unchanged. This shift in decision-making patterns brought their behavior closer to the healthy controls. Interestingly, the medication also slightly narrowed the decision threshold but unexpectedly increased the time participants spent encoding visual stimuli, potentially improving stimulus representation accuracy and contributing to improved accuracy. The severity of daily ADHD symptoms correlated with the participants' sensitivity to costs when unmedicated, with more severe cases displaying lower sensitivity.",
  "summary": "Adults with ADHD often struggle with choices that carry negative consequences. A new experiment reveals that stimulant medication improves decision-making by helping the brain process the potential costs of an action more efficiently.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}